Literature DB >> 2846879

Methylation of the promoter for an immediate-early frog virus 3 gene does not inhibit transcription.

J P Thompson1, A Granoff, D B Willis.   

Abstract

Methylation of critical sites within the promoter region of eucaryotic genes has been shown to inhibit transcription by RNA polymerase II. However, although the large DNA virus frog virus 3 (FV3) has a highly methylated genome, it uses host RNA polymerase II for at least the immediate-early stage of transcription. We have previously shown that an FV3-induced trans-acting protein allows transcription from adenovirus promoters inactivated by methylation. Since FV3 immediate-early genes are transcribed in the absence of de novo protein synthesis, it appears that the virus-induced trans-acting protein that allows transcription from methylated templates is not required for transcription of the immediate-early FV3 genes, possibly because they are not methylated in critical regulatory sequences. In this study, we used site-directed mutagenesis to alter the three CpG dinucleotide sequences in the promoter region of an immediate-early FV3 gene and thereby created sites recognized by bacterial methylases. Transient-expression assays demonstrated that neither the mutations nor methylation of the mutated sites inhibited transcription from the FV3 promoter in FV3-infected cells. These findings support the hypothesis that the immediate-early genes of FV3 do not contain methylatable sites in regions critical for transcription. The function of the virus-induced trans-acting protein that can override the inhibitory effect of methylation may therefore be to facilitate the transcription of methylated delayed-early or late FV3 genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846879      PMCID: PMC253581     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Detection of 5-methylcytosine in DNA sequences.

Authors:  H Ohmori; J I Tomizawa; A M Maxam
Journal:  Nucleic Acids Res       Date:  1978-05       Impact factor: 16.971

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Nongenetic reactivation of frog polyhedral cytoplasmic deoxyribovirus (PCDV).

Authors:  M Gravell; R F Naegele
Journal:  Virology       Date:  1970-01       Impact factor: 3.616

4.  Macromolecular synthesis in cells infected by frog virus 3. IX. Two temporal classes of early viral RNA.

Authors:  D B Willis; A Granoff
Journal:  Virology       Date:  1978-05-15       Impact factor: 3.616

5.  The nucleotide sequence of bacteriophage phiX174.

Authors:  F Sanger; A R Coulson; T Friedmann; G M Air; B G Barrell; N L Brown; J C Fiddes; C A Hutchison; P M Slocombe; M Smith
Journal:  J Mol Biol       Date:  1978-10-25       Impact factor: 5.469

6.  Nongenetic reactivation of frog virus 3 DNA.

Authors:  D B Willis; R Goorha; A Granoff
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

7.  Macromolecular synthesis in cells infected by frog virus 3. XI. A ts mutant of frog virus 3 that is defective in late transcription.

Authors:  D B Willis; R Goorha; A Granoff
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

8.  Regulation of simian virus 40 transcription: sensitive analysis of the RNA species present early in infections by virus or viral DNA.

Authors:  B A Parker; G R Stark
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  DNA sequences required for trans-activation of an immediate-early frog virus 3 gene.

Authors:  D B Willis
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

10.  The nucleotide sequence of oocyte 5S DNA in Xenopus laevis. II. The GC-rich region.

Authors:  J R Miller; E M Cartwright; G G Brownlee; N V Fedoroff; D D Brown
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

View more
  1 in total

1.  Patterns of frog virus 3 DNA methylation and DNA methyltransferase activity in nuclei of infected cells.

Authors:  C Schetter; B Grünemann; I Hölker; W Doerfler
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.